iQ Group Global Saliva Glucose Biosensor
The iQ Group Global has launched the Saliva Glucose Biosensor, a noninvasive, saliva-based glucose test for managing diabetes. According to the company, it is the first such test using saliva rather than blood for patient samples. The test comprises the Glucose Biosensor Unit and a digital healthcare app. The iQ Group Global added that it is working on a pilot research and development program with the University of Newcastle to expand beyond the saliva glucose diagnostic test and developing point-of-care diagnostic tests starting with tumor markers, hormones, and communicable diseases.